Literature DB >> 24314699

Parkinson disease in long term care facilities: a review of the literature.

Nico J Weerkamp1, Gerrit Tissingh2, Petra J E Poels3, Syste U Zuidema4, Marten Munneke3, Raymond T C M Koopmans5, Bastiaan R Bloem6.   

Abstract

Parkinson disease (PD) is common in long term care (LTC) facilities. The number of institutionalized patients with PD will rise sharply in the coming decades because of 2 concurrent phenomena: aging of the population leads to an increased PD prevalence and improved quality of care has led to a prolonged survival in advanced disease stages. Only a few studies have investigated the prevalence and clinical characteristics of patients with PD in LTC facilities. Even fewer studies have addressed the treatment strategies used to support these institutionalized patients, who are mostly in advanced stages of the disease. The available evidence suggests that current management of patients with PD in LTC facilities is less than optimal. In the Netherlands, and we suspect in many other countries, there are no formal guidelines for treating patients with PD who have been admitted to a LTC facility. In this review, we describe the epidemiology, clinical characteristics, and clinical management of patients with PD in LTC settings. We also address potentially modifiable elements of care and provide several recommendations to improve the management of PD in these facilities. We conclude by suggesting a possible guide for future research in this area.
Copyright © 2014 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Parkinson disease; diagnostic accuracy; long term care facilities; nursing homes; prevalence; review

Mesh:

Substances:

Year:  2013        PMID: 24314699     DOI: 10.1016/j.jamda.2013.10.007

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  11 in total

1.  Reaching Those Most in Need - A Call to Action for Advanced Parkinson's Disease.

Authors:  Shashank Agarwal; Jori E Fleisher
Journal:  Eur Neurol Rev       Date:  2016

Review 2.  [Parkinson's disease, Alzheimer's disease and oncological diseases in residential geriatric care : Pain frequency and selected healthcare features in comparison].

Authors:  P Kutschar; K Lex; J Osterbrink; S Lorenzl
Journal:  Schmerz       Date:  2018-10       Impact factor: 1.107

3.  Trends in inpatient antiparkinson drug use in the USA, 2001-2012.

Authors:  James A G Crispo; Yannick Fortin; Dylan P Thibault; Matthew Emons; Lise M Bjerre; Dafna E Kohen; Santiago Perez-Lloret; Donald Mattison; Allison W Willis; Daniel Krewski
Journal:  Eur J Clin Pharmacol       Date:  2015-06-18       Impact factor: 2.953

Review 4.  Patterns and Determinants of Prescribing for Parkinson's Disease: A Systematic Literature Review.

Authors:  Khalid Orayj; Emma Lane
Journal:  Parkinsons Dis       Date:  2019-11-03

5.  Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL).

Authors:  Jan H L Ypinga; Angelika D Van Halteren; Emily J Henderson; Bastiaan R Bloem; Agnes J Smink; Emma Tenison; Marten Munneke; Yoav Ben-Shlomo; Sirwan K L Darweesh
Journal:  BMC Neurol       Date:  2021-07-23       Impact factor: 2.474

6.  Low continuation of antipsychotic therapy in Parkinson disease - intolerance, ineffectiveness, or inertia?

Authors:  Thanh Phuong Pham Nguyen; Danielle S Abraham; Dylan Thibault; Daniel Weintraub; Allison W Willis
Journal:  BMC Neurol       Date:  2021-06-24       Impact factor: 2.474

7.  Baduanjin Qigong Intervention by Telerehabilitation (TeleParkinson): A Proof-of-Concept Study in Parkinson's Disease.

Authors:  Livia P Carvalho; Simon Décary; Isabelle Beaulieu-Boire; Rosalie Dostie; Isabelle Lalonde; Émilie Texier; Laurence Laprise; Elizabeth Pepin; Mélodie Gilbert; Hélène Corriveau; Michel Tousignant
Journal:  Int J Environ Res Public Health       Date:  2021-06-30       Impact factor: 3.390

Review 8.  Recommendations for Standards of Network Care for Patients with Parkinson's Disease in Germany.

Authors:  Tino Prell; Frank Siebecker; Michael Lorrain; Carsten Eggers; Stefan Lorenzl; Jochen Klucken; Tobias Warnecke; Carsten Buhmann; Lars Tönges; Reinhard Ehret; Ingmar Wellach; Martin Wolz
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

9.  Parkinson Matters.

Authors:  Sirwan K L Darweesh; Karen G Raphael; Patrik Brundin; Helen Matthews; Richard K Wyse; Honglei Chen; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

10.  Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson's Disease and Comorbid Depression.

Authors:  Farid Chekani; Holly M Holmes; Michael L Johnson; Hua Chen; Jeffrey T Sherer; Rajender R Aparasu
Journal:  Drug Healthc Patient Saf       Date:  2020-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.